by My Gene Counsel | Jun 17, 2020 | News
In the last six months, the world has learned that the SARS-CoV-2 virus, more commonly known as COVID-19, is contagious, can be deadly, and has become a global pandemic. As of today, more than 8.2 million people have tested positive, and more than 445,000 have died...
by My Gene Counsel | May 26, 2020 | News
Precision Oncology News and My Gene Counsel have partnered to produce the “Genetic Testing Challenges in Oncology” series to highlight real-world issues that genetics experts and medical professionals are encountering as genetic tests are increasingly used...
by user | Apr 6, 2020 | News
Precision Oncology News and My Gene Counsel have partnered to produce the “Genetic Testing Challenges in Oncology” series to highlight real-world issues that genetics experts and medical professionals are encountering as genetic tests are increasingly used...
by user | Mar 24, 2020 | News
Many healthcare systems in recent weeks have had to shift available resources and in-person care plans to increase capacity for a potential influx of SARS-CoV-2 infected patients. While some may consider germline genetic testing for assessing hereditary cancer risk a...
by user | Feb 24, 2020 | News
Precision Oncology News and My Gene Counsel have partnered to produce the “Genetic Testing Challenges in Oncology” series to highlight real-world issues that genetics experts and medical professionals are encountering as genetic tests are increasingly used...
by Jill Mastrianni | Feb 6, 2020 | News
Paired tumor/germline testing is far from standard practice in cancer care, but some experts in the field are advocating that when patients have their tumors genomically profiled to determine precision medicine options, that is an opportunity to also evaluate them for...
Recent Comments